FDG PET/CT in evaluation of unusual cutaneous manifestations of breast cancer

Shaylee R. Dave, Thomas A. Samuel, Darko Pucar, Natasha Marie Savage, Hadyn T Williams

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Cutaneous metastases of primary internal malignancies are rare, with an incidence of 0.7% to 10.4%. Cutaneous manifestations due to breast cancer are the most common metastases dermatologists observe, with a prevalence of 2.4% and an incidence of 23.9%. Presence of cutaneous metastases is usually a late event in disease progression, indicating grave prognosis. Recognition of cutaneous breast cancer metastases significantly alters therapeutic plans, especially when the disease was thought to be successfully cured. F-FDG PET CT imaging can detect cutaneous metastasis and sites of distant metastases and monitor response to therapy. We report 3 patients with cutaneous-predominant breast carcinoma seen by FDG PET/CT.

Original languageEnglish (US)
Pages (from-to)e63-e67
JournalClinical Nuclear Medicine
Volume40
Issue number1
DOIs
StatePublished - Jan 1 2015

Fingerprint

Skin Manifestations
Breast Neoplasms
Neoplasm Metastasis
Skin
Incidence
Skin Neoplasms
Disease Progression
Therapeutics
Neoplasms

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

FDG PET/CT in evaluation of unusual cutaneous manifestations of breast cancer. / Dave, Shaylee R.; Samuel, Thomas A.; Pucar, Darko; Savage, Natasha Marie; Williams, Hadyn T.

In: Clinical Nuclear Medicine, Vol. 40, No. 1, 01.01.2015, p. e63-e67.

Research output: Contribution to journalArticle

Dave, Shaylee R. ; Samuel, Thomas A. ; Pucar, Darko ; Savage, Natasha Marie ; Williams, Hadyn T. / FDG PET/CT in evaluation of unusual cutaneous manifestations of breast cancer. In: Clinical Nuclear Medicine. 2015 ; Vol. 40, No. 1. pp. e63-e67.
@article{aa133fe0d2804f0b9c8dca151fbf21dc,
title = "FDG PET/CT in evaluation of unusual cutaneous manifestations of breast cancer",
abstract = "Cutaneous metastases of primary internal malignancies are rare, with an incidence of 0.7{\%} to 10.4{\%}. Cutaneous manifestations due to breast cancer are the most common metastases dermatologists observe, with a prevalence of 2.4{\%} and an incidence of 23.9{\%}. Presence of cutaneous metastases is usually a late event in disease progression, indicating grave prognosis. Recognition of cutaneous breast cancer metastases significantly alters therapeutic plans, especially when the disease was thought to be successfully cured. F-FDG PET CT imaging can detect cutaneous metastasis and sites of distant metastases and monitor response to therapy. We report 3 patients with cutaneous-predominant breast carcinoma seen by FDG PET/CT.",
author = "Dave, {Shaylee R.} and Samuel, {Thomas A.} and Darko Pucar and Savage, {Natasha Marie} and Williams, {Hadyn T}",
year = "2015",
month = "1",
day = "1",
doi = "10.1097/RLU.0000000000000553",
language = "English (US)",
volume = "40",
pages = "e63--e67",
journal = "Clinical Nuclear Medicine",
issn = "0363-9762",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - FDG PET/CT in evaluation of unusual cutaneous manifestations of breast cancer

AU - Dave, Shaylee R.

AU - Samuel, Thomas A.

AU - Pucar, Darko

AU - Savage, Natasha Marie

AU - Williams, Hadyn T

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Cutaneous metastases of primary internal malignancies are rare, with an incidence of 0.7% to 10.4%. Cutaneous manifestations due to breast cancer are the most common metastases dermatologists observe, with a prevalence of 2.4% and an incidence of 23.9%. Presence of cutaneous metastases is usually a late event in disease progression, indicating grave prognosis. Recognition of cutaneous breast cancer metastases significantly alters therapeutic plans, especially when the disease was thought to be successfully cured. F-FDG PET CT imaging can detect cutaneous metastasis and sites of distant metastases and monitor response to therapy. We report 3 patients with cutaneous-predominant breast carcinoma seen by FDG PET/CT.

AB - Cutaneous metastases of primary internal malignancies are rare, with an incidence of 0.7% to 10.4%. Cutaneous manifestations due to breast cancer are the most common metastases dermatologists observe, with a prevalence of 2.4% and an incidence of 23.9%. Presence of cutaneous metastases is usually a late event in disease progression, indicating grave prognosis. Recognition of cutaneous breast cancer metastases significantly alters therapeutic plans, especially when the disease was thought to be successfully cured. F-FDG PET CT imaging can detect cutaneous metastasis and sites of distant metastases and monitor response to therapy. We report 3 patients with cutaneous-predominant breast carcinoma seen by FDG PET/CT.

UR - http://www.scopus.com/inward/record.url?scp=85028203886&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028203886&partnerID=8YFLogxK

U2 - 10.1097/RLU.0000000000000553

DO - 10.1097/RLU.0000000000000553

M3 - Article

C2 - 25140546

AN - SCOPUS:85028203886

VL - 40

SP - e63-e67

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

SN - 0363-9762

IS - 1

ER -